Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The mechanism of transglutaminase 2 inhibition with glucosamine: implications of a possible anti-inflammatory effect through transglutaminase inhibition.

Journal of cancer research and clinical oncology - 1 Jan 2010

Jeong Kyung-Chae, Ahn Kyung-Ohk, Lee Byung Il, Lee Chang-Hoon, Kim Soo-Youl

Abstract excerpt

PURPOSE: Although many efforts on revealing mechanism of the constitutive activation of NF-κB in cancer cells contributed to understanding canonical pathways, largely it remains to be determined for therapeutic approaches. Recently, we found that increased expression of transglutaminase 2 (TGase...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Inflammatory Agents
Share to Glucosamine
Share to Glucose-6-Phosphate

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Guanosine Triphosphate

Share to Guinea Pigs

Share to I-kappa B Kinase

Share to Protein Glutamine gamma Glutamyltransferase 2

Share to Transglutaminases

Source

Identifiers

PMID: 19655169
DOI: 10.1007/s00432-009-0645-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Prepared record publication-19655169-2026-09-05.1. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The mechanism of transglutaminase 2 inhibition with glucosamine: implications of a possible anti-inflammatory effect through transglutaminase inhibition.PMID 19655169Read ↗

Transglutaminase 2 takes center stage as a cancer cell survival factor and therapy targetSemantic proximity Read ↗

The Role of Transglutaminase 2 in Cancer: An UpdateSemantic proximity Read ↗

Transglutaminase-Mediated Activation of Nuclear Transcription Factor-&#954;B in Cancer Cells: A New Therapeutic OpportunitySemantic proximity Read ↗

Overexpression of Tissue Transglutaminase Leads to Constitutive Activation of Nuclear Factor-κB in Cancer Cells: Delineation of a Novel PathwaySemantic proximity Read ↗

Cell-Impermeable Inhibitors Confirm That Intracellular Human Transglutaminase 2 Is Responsible for the Transglutaminase-Associated Cancer Phenotype.Semantic proximity Read ↗

Tissue transglutaminase: a new target to reverse cancer drug resistanceSemantic proximity Read ↗

Evidence that GTP-binding domain but not catalytic domain of transglutaminase 2 is essential for epithelial-to-mesenchymal transition in mammary epithelial cells.Semantic proximity Read ↗

Nuclear Transglutaminase 2 interacts with topoisomerase II⍺ to promote DNA damage repair in lung cancer cellsSemantic proximity Read ↗

The Development of MetAP-2 Inhibitors in Cancer TreatmentSemantic proximity Read ↗

Transglutaminase 2 exacerbates ovarian cancer survival by inactivating GSK3βSemantic proximity Read ↗

Tissue transglutaminase expression promotes castration-resistant phenotype and transcriptional repression of androgen receptor.Semantic proximity Read ↗

Tissue transglutaminase: from biological glue to cell survival cues.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.